NHI NATIONAL HEALTH INVESTORS INC
Real Estate Investment Trusts · NYSE · SEC CIK 877860 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $113.48M | $121.32M | $115.13M | $105.82M | $89.85M | $90.66M | $89.30M | $85.75M |
| SG&A expense | $8.01M | $8.82M | $7.85M | $7.60M | $6.31M | $6.12M | $6.83M | $5.42M |
| Interest expense | $12.52M | $15.81M | $15.04M | $14.26M | $13.77M | $15.00M | $14.34M | $15.24M |
| Pretax income | $562.80M | $56.09M | — | — | $32.41M | $35.16M | — | — |
| Income tax | $279,000 | $732,000 | — | — | $0 | $0 | — | — |
| Net income | $563.52M | $55.67M | $40.10M | $38.16M | $32.86M | $36.99M | $34.16M | $43.24M |
| EPS (basic) | 11.47 | 1.15 | 0.83 | — | 0.69 | 0.79 | 0.75 | — |
| EPS (diluted) | 11.47 | 1.15 | 0.82 | — | 0.69 | 0.79 | 0.74 | — |
| Dividends declared per share | 0.94 | 0.92 | 0.92 | 0.92 | 0.92 | 0.90 | 0.90 | 0.90 |
| Weighted avg. shares (diluted) | 49.04M | 48.50M | 48.55M | — | 47.62M | 46.82M | 45.88M | — |
| Banking | ||||||||
| Loans, net | $209.44M | $209.27M | $205.95M | $203.30M | $209.17M | $252.94M | $259.77M | $268.93M |
| Balance sheet | ||||||||
| Cash & equivalents | $46.56M | $30.39M | $24.95M | $19.62M | $81.62M | $18.64M | $135.00M | $24.29M |
| PP&E, net | $2.53B | $2.57B | $2.56B | $2.47B | $2.30B | $2.32B | $2.27B | $2.21B |
| Total assets | $3.24B | $2.96B | $2.89B | $2.80B | $2.69B | $2.70B | $2.78B | $2.61B |
| Total liabilities | $1.14B | $1.37B | $1.36B | $1.26B | $1.19B | $1.20B | $1.34B | $1.23B |
| Shareholders' equity | $2.09B | $1.57B | $1.51B | $1.52B | $1.48B | $1.48B | $1.43B | $1.37B |
| Shares outstanding | 48.30M | 48.30M | 48.30M | 48.30M | 45.69M | 45.69M | 45.69M | 45.69M |
| Cash flow statement | ||||||||
| Operating cash flow | $47.98M | $64.97M | $53.44M | $67.74M | $62.53M | $59.82M | $46.48M | $57.57M |
| Capital expenditure | — | — | $109.42M | $143.30M | — | — | $85.17M | $110.84M |
| Free cash flow | — | — | -$55.98M | -$75.56M | — | — | -$38.69M | -$53.27M |
| Investing cash flow | $460.40M | -$43.41M | -$103.89M | -$187.03M | $41.67M | -$48.32M | -$75.47M | -$161.20M |
| Financing cash flow | -$280.51M | $3.93M | $55.77M | $57.29M | -$41.90M | -$129.46M | $139.77M | $112.36M |
| Depreciation & amortization | $25.76M | $25.55M | $23.69M | $21.65M | $20.22M | $19.92M | $19.16M | $18.68M |
| Stock-based compensation | $1.46M | $2.36M | $2.24M | $964,000 | $983,000 | $1.07M | $2.56M | $670,000 |
| Dividends paid | $45.19M | $44.58M | $44.44M | $43.83M | $42.73M | $42.02M | $41.12M | $39.26M |
Free plan shows the latest 8 periods; Pro shows all 70 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.